YC W15
Shasqi
Targeting Cancer with Click Chemistry
About
Shasqi is leading the development of therapeutics leveraging click chemistry to get active cancer treatments to tumors with its proprietary CAPAC™ platform. Our technology is based on localizing a click chemistry reagent in the tumor area, which then activates a second agent, a systemically infused protodrug. When the two 'click', a powerful localized therapy is activated at the tumor, while keeping its systemic exposure levels below toxic thresholds.
Founder
- Jose M. Mejia Oneto
Family Office Investors
2 deals trackedAltss has tracked family office activity in Shasqi. Investors shown are from our private markets database.
- Juan Jaen (Angel)
- Mark McCamish (Angel)
Industry & Focus
HealthcareDrug Discovery and DeliveryBiotechTherapeutics